{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:54:09Z","timestamp":1770886449126,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Radiation dose to the rectum in prostate brachytherapy (PBT) can be reduced by the use of polyethylene glycol (PEG) hydrogel spacers. This reduces the rate of rectal toxicity and allows dose escalation to the prostate. Our objectives were to provide an overview of technique for injection of a PEG hydrogel spacer, reduction in rectal dosimetry, gastrointestinal toxicity and potential complications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We systematically reviewed the role of PEG hydrogel spacers in PBT using the Cochrane and PRISMA methodology for all English-language articles from January 2013 to December 2019. Data was extracted for type of radiotherapy, number of patients, type of PEG-hydrogel used, mean prostate-rectum separation, rectal dosimetry, acute and late GI toxicity, procedure-related complications and the technique used for hydrogel insertion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Nine studies (671 patients and 537 controls) met our inclusion criteria. Of these 4 used DuraSeal<jats:sup>\u00ae<\/jats:sup> and 5 used SpaceOAR<jats:sup>\u00ae<\/jats:sup>. The rectal spacing achieved varied between 7.7-16\u00a0mm. Failure of hydrogel insertion was seen only in 12 patients, mostly related to failure of hydrodissection in patients undergoing salvage PBT. Where reported, the rectal D2 cc was reduced by between 21.6 and 52.6% and the median rectal V75% cc was reduced by between 91.8\u2013100%. Acute GI complications were mostly limited to grade 1 or 2 toxicity (<jats:italic>n<\/jats:italic>\u2009=\u2009153, 33.7%) with low levels of grade 3 or 4 toxicity (<jats:italic>n<\/jats:italic>\u2009=\u20091, 0.22%). Procedure-related complications were limited to tenesmus (0.14%), rectal discomfort (1.19%), and bacterial prostatitis (0.44%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>PEG hydrogel spacers are safe to insert. Gel insertion is easy, fast and has a low rate of failure. These studies convincingly demonstrate a significant reduction in rectal dosimetry. Although the results of spacers in reducing rectal toxicity is promising, these need to be confirmed in prospective randomised trial.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-020-03414-6","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T14:02:51Z","timestamp":1598364171000},"page":"1769-1780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique"],"prefix":"10.1007","volume":"39","author":[{"given":"S.","family":"Vaggers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. P.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. C. P.","family":"Chedgy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"de la Taille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6248-6478","authenticated-orcid":false,"given":"B. K.","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"3414_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.soc.2017.01.008","volume":"26","author":"BJ Stish","year":"2017","unstructured":"Stish BJ, Davis BJ, Mynderse LA et al (2017) Brachytherapy in the management of prostate cancer. Surg Oncol Clin N Am 26:491\u2013513","journal-title":"Surg Oncol Clin N Am"},{"key":"3414_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1200\/JCO.2019.37.7_suppl.21","volume":"37","author":"V Muralidhar","year":"2019","unstructured":"Muralidhar V, Mahal BAV, Yang DD et al (2019) External beam radiation therapy and brachytherapy boost versus radical prostatectomy and adjuvant radiation therapy for high-risk prostate cancer. J Clin Oncol 37:21\u201321","journal-title":"J Clin Oncol"},{"key":"3414_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.08.017","author":"K Martell","year":"2019","unstructured":"Martell K, Mendez LC, Chung HT et al (2019) Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: analysis of over 500 patients. Radiother Oncol. https:\/\/doi.org\/10.1016\/j.radonc.2019.08.017","journal-title":"Radiother Oncol"},{"key":"3414_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctro.2019.10.001","volume":"20","author":"F Slevin","year":"2020","unstructured":"Slevin F, Rodda SL, Bownes P et al (2020) A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy. Clin Transl Radiat Oncol 20:1\u20138","journal-title":"Clin Transl Radiat Oncol"},{"key":"3414_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5114\/jcb.2013.34342","volume":"5","author":"J Skowronek","year":"2013","unstructured":"Skowronek J (2013) Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer: between options. J Contemp Brachytherapy 5:33\u201341","journal-title":"J Contemp Brachytherapy"},{"key":"3414_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.brachy.2013.05.004","volume":"13","author":"O Marina","year":"2014","unstructured":"Marina O, Gustafson GS, Kestin LL et al (2014) Comparison of dose-escalated, image-guided radiotherapy vs dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients. Brachytherapy 13:59\u201367","journal-title":"Brachytherapy"},{"key":"3414_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brachy.2016.09.006","volume":"16","author":"DE Spratt","year":"2017","unstructured":"Spratt DE, Soni PD, McLaughlin PW et al (2017) American Brachytherapy Society Task Group Report: combination of brachytherapy and external beam radiation for high-risk prostate cancer. Brachytherapy 16:1\u201312","journal-title":"Brachytherapy"},{"key":"3414_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ctrv.2018.10.004","volume":"70","author":"DLC Kee","year":"2018","unstructured":"Kee DLC, Gal J, Falk AT et al (2018) Brachytherapy versus external beam radiotherapy boost for prostate cancer: systematic review with meta-analysis of randomized trials. Cancer Treat Rev 70:265\u2013271","journal-title":"Cancer Treat Rev"},{"key":"3414_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0360-3016(01)01442-0","volume":"50","author":"KM Snyder","year":"2001","unstructured":"Snyder KM, Stock RG, Hong SM et al (2001) Defining the risk of developing Grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 50:335\u2013341","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.brachy.2011.05.007","volume":"11","author":"M Keyes","year":"2012","unstructured":"Keyes M, Spadinger I, Liu M et al (2012) Rectal toxicity and rectal dosimetry in low-dose-rate 125I permanent prostate implants: a long-term study in 1006 patients. Brachytherapy 11:199\u2013208","journal-title":"Brachytherapy"},{"key":"3414_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012529.pub2","author":"TA Lawrie","year":"2018","unstructured":"Lawrie TA, Green JT, Beresford M et al (2018) Interventions to reduce acute and late adverse gastrointestinal effects of pelvic radiotherapy for primary pelvic cancers. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD012529.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"3414_CR12","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijrobp.2014.06.044","volume":"90","author":"G Mok","year":"2014","unstructured":"Mok G, Benz E, Vallee JP et al (2014) Optimization of radiation therapy techniques for prostate cancer with prostate-rectum spacers: a systematic review. Int J Radiat Oncol Biol Phys 90:278\u2013288","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.brachy.2017.11.006","volume":"17","author":"AS Taggar","year":"2018","unstructured":"Taggar AS, Charas T, Cohen GN et al (2018) Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103. Brachytherapy 17:251\u2013258","journal-title":"Brachytherapy"},{"key":"3414_CR14","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.brachy.2014.05.001","volume":"13","author":"BA Mahal","year":"2014","unstructured":"Mahal BA, Ziehr DR, Hyatt AS et al (2014) Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results. Brachytherapy 13:442\u2013449","journal-title":"Brachytherapy"},{"key":"3414_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.radonc.2014.08.012","volume":"112","author":"VP Heikkil\u00e4","year":"2014","unstructured":"Heikkil\u00e4 VP, K\u00e4rn\u00e4 A, Vaarala MH (2014) DuraSeal\u00ae as a spacer to reduce rectal doses in low-dose rate brachytherapy for prostate cancer. Radiother Oncol 112:233\u2013236","journal-title":"Radiother Oncol"},{"key":"3414_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.brachy.2017.10.014","volume":"17","author":"SY Wu","year":"2018","unstructured":"Wu SY, Boreta L, Wu A et al (2018) Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy. Brachytherapy 17:259\u2013264","journal-title":"Brachytherapy"},{"key":"3414_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/1754-9485.12882","volume":"63","author":"M Chao","year":"2019","unstructured":"Chao M, Bolton D, Lim Joon D et al (2019) High dose rate brachytherapy boost for prostate cancer: biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes. J Med Imaging Radiat Oncol 63:415\u2013421","journal-title":"J Med Imaging Radiat Oncol"},{"key":"3414_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5114\/jcb.2019.82836","volume":"11","author":"M Chao","year":"2019","unstructured":"Chao M, Ow D, Ho H et al (2019) Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space. J Contemp Brachytherapy 11:8\u201313","journal-title":"J Contemp Brachytherapy"},{"key":"3414_CR19","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.radonc.2014.02.011","volume":"111","author":"TJ Strom","year":"2014","unstructured":"Strom TJ, Wilder RB, Fernandez DC et al (2014) A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy \u00b1 intensity modulated radiation therapy. Radiother Oncol 111:126\u2013131","journal-title":"Radiother Oncol"},{"key":"3414_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.brachy.2015.12.007","volume":"15","author":"J Yeh","year":"2016","unstructured":"Yeh J, Lehrich B, Tran C et al (2016) Polyethylene glycol hydrogel rectal spacer implantation in patients with prostate cancer undergoing combination high-dose-rate brachytherapy and external beam radiotherapy. Brachytherapy 15:283\u2013287","journal-title":"Brachytherapy"},{"key":"3414_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/iju.14123","author":"M Morita","year":"2019","unstructured":"Morita M, Fukagai T, Hirayama K et al (2019) Placement of SpaceOAR hydrogel spacer for prostate cancer patients treated with iodine-125 low-dose-rate brachytherapy. Int J Urol. https:\/\/doi.org\/10.1111\/iju.14123","journal-title":"Int J Urol"},{"key":"3414_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijrobp.2012.12.019","volume":"87","author":"DY Song","year":"2013","unstructured":"Song DY, Herfarth KK, Uhl M et al (2013) A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys 87:81\u201387","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR23","first-page":"9288","volume":"25","author":"J Montoya","year":"2018","unstructured":"Montoya J, Gross E, Karsh L (2018) How I do it: hydrogel spacer placement in men scheduled to undergo prostate radiotherapy. Can J Urol 25:9288\u20139293","journal-title":"Can J Urol"},{"key":"3414_CR24","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ijrobp.2009.07.1679","volume":"76","author":"RC Susil","year":"2010","unstructured":"Susil RC, McNutt TR, DeWeese TL et al (2010) Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. Int J Radiat Oncol Biol Phys 76:1251\u20131258","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-206931","author":"AYM Teh","year":"2014","unstructured":"Teh AYM, Ko HT, Barr G et al (2014) Rectal ulcer associated with SpaceOAR hydrogel insertion during prostate brachytherapy. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2014-206931","journal-title":"BMJ Case Rep"},{"key":"3414_CR26","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.brachy.2013.01.164","volume":"12","author":"N Beydoun","year":"2013","unstructured":"Beydoun N, Bucci JA, Chin YS et al (2013) First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy. Brachytherapy 12:368\u2013374","journal-title":"Brachytherapy"},{"key":"3414_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.brachy.2012.03.005","volume":"12","author":"PL Nguyen","year":"2013","unstructured":"Nguyen PL, Devlin PM, Beard CJ et al (2013) High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: Case report and review of the literature. Brachytherapy 12:77\u201383","journal-title":"Brachytherapy"},{"key":"3414_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5114\/jcb.2018.75602","volume":"10","author":"R Hepp","year":"2018","unstructured":"Hepp R, Eggert T, Schabl G et al (2018) Salvage high-dose-rate brachytherapy for prostate cancer persistence after brachytherapy: Repeated use of a polyethylene glycol hydrogel spacer. J Contemp Brachytherapy 10:169\u2013173","journal-title":"J Contemp Brachytherapy"},{"key":"3414_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0022-5347(17)36209-2","volume":"149","author":"A Villers","year":"1993","unstructured":"Villers A, McNeal JE, Freiha FS et al (1993) Invasion of Denonvilliers\u2019 fascia in radical prostatectomy specimens. J Urol 149:793\u2013798","journal-title":"J Urol"},{"key":"3414_CR30","doi-asserted-by":"publisher","first-page":"E647","DOI":"10.1111\/j.1464-410X.2012.11373.x","volume":"110","author":"G Hatiboglu","year":"2012","unstructured":"Hatiboglu G, Pinkawa M, Vall\u00e9e J-P et al (2012) Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy. BJU Int 110:E647\u2013E652","journal-title":"BJU Int"},{"key":"3414_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-8-96","author":"E Gez","year":"2013","unstructured":"Gez E, Cytron S, Yosef RB et al (2013) Application of an interstitial and biodegradable balloon system for prostate-rectum separation during prostate cancer radiotherapy: A prospective multi-center study. Radiat Oncol. https:\/\/doi.org\/10.1186\/1748-717X-8-96","journal-title":"Radiat Oncol"},{"key":"3414_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijrobp.2007.02.034","volume":"69","author":"PJ Prada","year":"2007","unstructured":"Prada PJ, Fern\u00e1ndez J, Martinez AA et al (2007) Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Radiat Oncol Biol Phys 69:95\u2013102","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR33","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.apradiso.2009.10.022","volume":"68","author":"E Daar","year":"2010","unstructured":"Daar E, King L, Nisbet A et al (2010) Viscosity changes in hyaluronic acid: Irradiation and rheological studies. Appl Radiat Isot 68:746\u2013750","journal-title":"Appl Radiat Isot"},{"key":"3414_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.urpr.2014.03.004","volume":"1","author":"BA Mahal","year":"2014","unstructured":"Mahal BA, O\u2019Leary MP, Nguyen PL (2014) Hydrogel spacing for radiotherapy of prostate cancer: a review of the literature. Urol Pract 1:79\u201385","journal-title":"Urol Pract"},{"key":"3414_CR35","first-page":"435","volume":"27","author":"CF Ramel","year":"2012","unstructured":"Ramel CF, Wismeijer DA, H\u00e4mmerle CHF et al (2012) A randomized, controlled clinical evaluation of a synthetic gel membrane for guided bone regeneration around dental implants: clinical and radiologic 1- and 3-year results. Int J Oral Maxillofac Implants 27:435\u2013441","journal-title":"Int J Oral Maxillofac Implants"},{"key":"3414_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1748-717X-9-96","volume":"9","author":"M Uhl","year":"2014","unstructured":"Uhl M, Herfarth K, Eble MJ et al (2014) Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 month toxicity and proctoscopy results of a prospective multicenter phase II trial. Radiat Oncol 9:96","journal-title":"Radiat Oncol"},{"key":"3414_CR37","volume-title":"Summary of safety and effectiveness data","author":"Food and Drug Administration","year":"2020","unstructured":"Food and Drug Administration (2020) Summary of safety and effectiveness data. FDA, Washington"},{"key":"3414_CR38","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ijrobp.2005.03.046","volume":"63","author":"MPR Van Gellekom","year":"2005","unstructured":"Van Gellekom MPR, Moerland MA, Van Vulpen M et al (2005) Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Int J Radiat Oncol Biol Phys 63:772\u2013780","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR39","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ijrobp.2015.04.030","volume":"92","author":"N Mariados","year":"2015","unstructured":"Mariados N, Sylvester J, Shah D et al (2015) Hydrogel spacer prospective multicenter randomized controlled pivotal trial: dosimetric and clinical effects of perirectal spacer application in men undergoing prostate image guided intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 92:971\u2013977","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.urology.2017.11.016","volume":"115","author":"IK Lawrence","year":"2018","unstructured":"Lawrence IK, Gross ET, Christopher MP et al (2018) Absorbable hydrogel spacer use in prostate radiotherapy: a comprehensive review of phase 3 clinical trial published data. Urology 115:39\u201344","journal-title":"Urology"},{"key":"3414_CR41","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","volume":"97","author":"DA Hamstra","year":"2017","unstructured":"Hamstra DA, Mariados N, Sylvester J et al (2017) Continued benefit to rectal separation for prostate radiation therapy: final results of a Phase III trial. Int J Radiat Oncol Biol Phys 97:976\u2013985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3414_CR42","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.prro.2017.07.008","volume":"8","author":"AH Daniel","year":"2018","unstructured":"Daniel AH, Neil M, John S et al (2018) Sexual quality of life following prostate intensity modulated radiation therapy (IMRT) with a rectal\/prostate spacer: secondary analysis of a phase 3 trial. Pract Radiat Oncol 8:e7\u2013e15","journal-title":"Pract Radiat Oncol"},{"key":"3414_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1089\/end.2019.0431","volume":"33","author":"A Aminsharifi","year":"2019","unstructured":"Aminsharifi A, Kotamarti S, Silver D et al (2019) Major complications and adverse events related to the injection of the SpaceOAR hydrogel system before radiotherapy for prostate cancer: review of the manufacturer and user facility device experience database. J Endourol 33:868\u2013871","journal-title":"J Endourol"},{"key":"3414_CR44","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.brachy.2014.02.263","volume":"13","author":"N Leong","year":"2014","unstructured":"Leong N, Pai H, Morris WJ (2014) Rectal ulcers and rectoprostatic fistulas following I-125 LDR prostate brachytherapy. Brachytherapy 13:S40","journal-title":"Brachytherapy"},{"key":"3414_CR45","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/cncr.22941","volume":"110","author":"PL Nguyen","year":"2007","unstructured":"Nguyen PL, D\u2019Amico AV, Lee AK et al (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure. Cancer 110:1417\u20131428","journal-title":"Cancer"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-020-03414-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-020-03414-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T23:34:51Z","timestamp":1629848091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-020-03414-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3414"],"URL":"https:\/\/doi.org\/10.1007\/s00345-020-03414-6","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"14 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no potential conflict of interest for any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"As this is a systematic review there was no research involving Human Participants and\/or Animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"As this is a systematic review no Informed consent was needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}